In our previous article (see here) we reported the ongoing extremely poor performances in the constituents of the munKNEE Canadian Cannabis LPs Index (DOWN 12.3% MTD and DOWN 27.4% YTD). Perhaps you should consider investing in those companies that have major financial investments in many of the LPs. I am referring to the munKNEE Conservative "Cannabis" Stocks Index which is UP 2.2% MTD and UP 1.0% YTD, in comparison, and has an average dividend yield of 2.9% to boot. 

The munKNEE Conservative "Cannabis" Stocks Index consists of 3 tobacco companies, 2 beer companies, and 1 liquor company that are significantly invested in cannabis companies and they are presented below as to:

• their stock performances MTD and YTD and as compared to the Canadian cannabis companies they are part-owners of, 
• their average Wall Street analyst consensus 12-month Price Targets,
• their consensus Buy/Hold/Sell ratings,
• their current Dividend Yield, and
• their projected Price/Earnings Ratios (FWD).

1. Molson Coors (TAP): UP 11.6% MTD; UP 12.3% YTD
   • has a 57.5%/42.5% joint venture, called TRUSS, with Hexo Corp. (HEXO): DOWN 11.2% MTD; UP 17.8% YTD.
   • 21 analysts:
     • have an average 12-month price target representing a 4.5% DECREASE from its current price,
     • have a consensus HOLD rating,
   • has a dividend yield of 2.7% and
   • has a projected price/earnings ratio (FWD) of 14.7
2. Imperial Brands (IMBBY): UP 4.4% MTD; DOWN 2.8% YTD
   • has a 19.9% stake in Auxly Cannabis Group (CBWTF): DOWN 14.3% MTD; DOWN 18.9% YTD.
   • 1 analyst:
     • has an average 12-month price target representing a 40.4% increase from its current price,
     • has a BUY rating, 
   • has a dividend yield of 7.0% and
   • has a projected Price/Earnings Ratio (FWD) of 13.1
3. Altria Group (MO): UP 3.1% MTD; UP 0.8% YTD 
   • has a 45% stake in Cronos Group (CRON), DOWN 5.7% MTD; DOWN 27.4% YTD.
   • 17 analysts:
     • have an average 12-month price target representing an 8.3% increase from its current price,
     • have a consensus HOLD rating,
   • has a dividend yield of 8.2% and
   • has a projected price/earnings ratio (FWD) of 8.8
4. British American Tobacco (BTI): UP 2.9% MTD; DOWN 9.5% YTD
   • has a C$221M investment and product development partnership with Organigram Holdings (OGI): DOWN 18.8% MTD; Down 33.3% YTD.
   • has a $56.8 million investment in Charlotte’s Web Holdings (CWBHF), (UP 16.4% MTD; DOWN 31.4% YTD), in the form of a convertible debenture which, if converted (at BTI's discretion), would equate to a 19.9% ownership position in the company,
   • 4 analysts:
     • have an average 12-month price target representing a 42.2% increase from its current price,
     • have a consensus BUY rating,
   • has a dividend yield of 7.4% and
   • has a projected price/earnings ratio (FWD) of 8.4
5. Constellation Brands (STZ): UP 0.5% MTD; DOWN 1.7% YTD
   • has a 39% stake in Canopy Growth (CGC): DOWN 22.9% MTD; DOWN 40.5% YTD.
   • 28 analysts:
     • have an average 12-month price target representing just a 12.6% increase from its current price,
     • have a consensus BUY rating,
   • has a dividend yield of 1.6% and
   • has a projected price/earnings ratio (FWD) of 19.4
6. Anheuser-Busch (BUD): DOWN 1.9% MTD; UP 9.2% YTD
   • has a $100 million joint venture with Tilray (TLRY): DOWN 8.3% MTD; Down 13.1% YTD.
   • 9 analysts:
     • have an average 12-month price target representing a 6.4% increase from its current price,
     • have a consensus BUY rating,
   • has a dividend yield of 1.3% and
   • has a projected price/earnings ratio (FWD) of 19.8

In summary, the munKNEE Conservative "Cannabis" Stocks Index:

• is UP 2.2% MTD and is UP 1.0% YTD
• and its constituents currently have an average dividend yield of 2.9% and
• the average 12-month price targets mentioned above represent a 12.9% increase from their current prices.

More By This Author:

Canadian Cannabis LPs Continue To Plummet In April
These 44 Gold Analysts Provide Specific Forecast Dates
ETFs Outperforming The S&P 500, On Average